Cellectis Correlations

CLLS Stock

USD 3.90 0.09 2.26%

The current 90-days correlation between Cellectis SA and Alto Neuroscience is 0.24 (i.e., Modest diversification). The correlation of Cellectis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Cellectis Correlation With Market

Excellent diversification

The correlation between Cellectis SA and DJI is -0.54 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cellectis SA and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Cellectis Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Moving together with Cellectis Stock

0.79	OSE	OSE Pharma SA	Pair Corr
0.77	VCYT	Veracyte Earnings Call This Week	Pair Corr
0.75	BIM	Biomerieux SA Earnings Call This Week	Pair Corr

Moving against Cellectis Stock

0.7	6C1	CytomX Therapeutics	Pair Corr
0.7	DRTS	Alpha Tau Medical	Pair Corr
0.63	PYC	Physiomics Plc	Pair Corr
0.58	CMB	Cambium Bio Earnings Call This Week	Pair Corr
0.55	8VP1	AVRICORE HEALTH INC	Pair Corr
0.55	DNTH	Dianthus Therapeutics	Pair Corr
0.51	GXEA	Galapagos NV Earnings Call Tomorrow	Pair Corr
0.48	DNLI	Denali Therapeutics Earnings Call Next Week	Pair Corr
0.46	VALN	Valneva SE ADR	Pair Corr
0.45	EQ	Equillium	Pair Corr
0.44	2CG	NANOSPHERE HEASCIENCES	Pair Corr
0.43	H2K2	XTL Biopharmaceuticals Split	Pair Corr
0.33	JUMP	Leveljump Healthcare Corp Earnings Call Next Week	Pair Corr
0.32	AVH	Avita Medical	Pair Corr
0.31	DSGN	Design Therapeutics	Pair Corr
0.73	S09	Sutro Biopharma Split	Pair Corr
0.65	0P6S	Bayer AG NA	Pair Corr
0.65	ALA	Arovella Therapeutics Earnings Call This Week	Pair Corr
0.64	SRZNW	Surrozen Warrant	Pair Corr
0.51	VRTX	Vertex Pharmaceuticals	Pair Corr
0.47	DVAX	Dynavax Technologies	Pair Corr
0.42	NANO	Nanobiotix SA	Pair Corr
0.32	TF2	Takara Bio	Pair Corr

Related Correlations Analysis

	ANRO	ACIU	ALDX	AMRN	DRTS	LRMR	SLN	DBVT	MREO	KRRO
ANRO		0.2	0.06	-0.43	0.46	-0.02	-0.14	0.62	-0.25	0.38	ANRO
ACIU	0.2		-0.31	-0.04	0.38	0.04	-0.17	0.25	-0.4	0.2	ACIU
ALDX	0.06	-0.31		0.01	0.06	0.11	-0.24	0.31	0.0	0.29	ALDX
AMRN	-0.43	-0.04	0.01		0.03	-0.47	-0.06	-0.31	-0.14	-0.07	AMRN
DRTS	0.46	0.38	0.06	0.03		-0.46	-0.68	0.79	-0.79	0.9	DRTS
LRMR	-0.02	0.04	0.11	-0.47	-0.46		0.55	-0.1	0.58	-0.33	LRMR
SLN	-0.14	-0.17	-0.24	-0.06	-0.68	0.55		-0.53	0.67	-0.74	SLN
DBVT	0.62	0.25	0.31	-0.31	0.79	-0.1	-0.53		-0.55	0.83	DBVT
MREO	-0.25	-0.4	0.0	-0.14	-0.79	0.58	0.67	-0.55		-0.72	MREO
KRRO	0.38	0.2	0.29	-0.07	0.9	-0.33	-0.74	0.83	-0.72		KRRO
	ANRO	ACIU	ALDX	AMRN	DRTS	LRMR	SLN	DBVT	MREO	KRRO

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

KRRO	+ 0.9	DRTS
KRRO	+ 0.83	DBVT
DBVT	+ 0.79	DRTS
MREO	+ 0.67	SLN
DBVT	+ 0.62	ANRO
MREO	+ 0.58	LRMR

High negative correlations

MREO	- 0.79	DRTS
KRRO	- 0.74	SLN
KRRO	- 0.72	MREO
SLN	- 0.68	DRTS
MREO	- 0.55	DBVT
DBVT	- 0.53	SLN

Risk-Adjusted Indicators

There is a big difference between Cellectis Stock performing well and Cellectis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cellectis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ANRO	3.93	0.71	0.12	(3.20)	4.50	(4.07)	10.64	(8.77)	22.90
ACIU	3.63	(0.47)	0.00	(0.13)	0.00	0.00	7.01	(8.38)	26.05
ALDX	3.53	0.12	0.01	(1.71)	4.22	(4.15)	6.27	(8.84)	42.93
AMRN	2.33	(0.01)	(0.02)	0.03	2.74	(2.86)	4.94	(3.95)	21.26
DRTS	4.15	0.93	0.24	0.33	3.70	(4.88)	10.48	(7.29)	29.36
LRMR	3.30	(0.17)	0.00	(0.14)	0.00	0.00	6.96	(6.40)	20.14
SLN	3.32	(0.26)	0.00	0.73	0.00	0.00	7.72	(5.89)	23.80
DBVT	4.44	0.97	0.19	(1.20)	4.02	(5.43)	10.53	(6.81)	36.36
MREO	7.05	(0.17)	0.00	(0.02)	0.00	0.00	16.33	(9.52)	101.95
KRRO	3.83	0.89	0.25	0.53	3.14	(4.32)	10.98	(5.87)	20.29

Cellectis Corporate Management

Dr MBA	Chief Officer	Profile
Steven Doares	North Raleigh	Profile
Valerie Cros	Principal Officer	Profile
Philippe Duchateau	Chief Scientific Officer	Profile
Pascalyne Wilson	Director Communications	Profile
MBA MD	Chief Officer	Profile
Arthur Stril	Interim Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC